Guidelines for the management of oesophageal and gastric cancer
Open Access
- 1 June 2002
- Vol. 50 (Supplement), v1-v23
- https://doi.org/10.1136/gut.50.suppl_5.v1
Abstract
Over the past 10 years there have been many significant changes in the management of oesophageal and gastric cancer. Both diseases have shown remarkable changes in epidemiology with a concentration of tumours adjacent to the oesophagogastric junction. Advances in established investigative techniques and developments in new technology have radically altered the way in which the two diseases can be assessed without the need for surgery. Greater understanding of the natural history has significantly influenced the approach to diagnosis and to treatment options. Appreciation of the fundamental need for multidisciplinary treatment planning has reflected greater recognition by all interested clinicians of the role of the various treatment modalities. The essential role of best supportive care has significantly evolved emphasising the need for a holistic approach to all patients.Keywords
This publication has 97 references indexed in Scilit:
- Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinomaEuropean Journal of Surgical Oncology, 2000
- Chemotherapy for operable gastric cancer: results of the Dutch randomised FAMTX trialEuropean Journal Of Cancer, 1999
- A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapyGastrointestinal Endoscopy, 1996
- Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective studyGastrointestinal Endoscopy, 1996
- Prior radiation and chemotherapy increase the risk of life-threatening complications after insertion of metallic stents for esophagogastric malignancyGastrointestinal Endoscopy, 1996
- Nd-YAG laser as a palliative treatment for malignant dysphagiaEuropean Journal of Surgical Oncology, 1996
- Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancerBritish Journal of Cancer, 1995
- Laparoscopy and laparoscopic ultrasound for staging of upper gastrointestinal tumoursEuropean Journal of Surgical Oncology, 1995
- Neoadjuvant chemotherapy in locally advanced gastric carcinoma—a phase II trial with combined continuous intravenous 5-fluorouracil and bolus cisplatinumEuropean Journal Of Cancer, 1994
- Multifactorial Index of Cardiac Risk in Noncardiac Surgical ProceduresNew England Journal of Medicine, 1977